Redefining the MED13L syndrome

Abidemi Adegbola, Luciana Musante, Bert Callewaert, Patricia Maciel, Hao Hu, Bertrand Isidor, Sylvie Picker-Minh, Cedric Le Caignec, Barbara Delle Chiaie, Olivier Vanakker, Björn Menten, Annelies Dheedene, Nele Bockaert, Filip Roelens, Karin Decaestecker, João Silva, Gabriela Soares, Fátima Lopes, Hossein Najmabadi, Kimia KahriziGerald F. Cox, Steven P. Angus, John F. Staropoli, Ute Fischer, Vanessa Suckow, Oliver Bartsch, Andrew Chess, Hans Hilger Ropers, Thomas F. Wienker, Christoph Hübner, Angela M. Kaindl, Vera M. Kalscheuer

Research output: Contribution to journalArticlepeer-review

46 Scopus citations


Congenital cardiac and neurodevelopmental deficits have been recently linked to the mediator complex subunit 13-like protein MED13L, a subunit of the CDK8-associated mediator complex that functions in transcriptional regulation through DNA-binding transcription factors and RNA polymerase II. Heterozygous MED13L variants cause transposition of the great arteries and intellectual disability (ID). Here, we report eight patients with predominantly novel MED13L variants who lack such complex congenital heart malformations. Rather, they depict a syndromic form of ID characterized by facial dysmorphism, ID, speech impairment, motor developmental delay with muscular hypotonia and behavioral difficulties. We thereby define a novel syndrome and significantly broaden the clinical spectrum associated with MED13L variants. A prominent feature of the MED13L neurocognitive presentation is profound language impairment, often in combination with articulatory deficits.

Original languageEnglish
Pages (from-to)1308-1317
Number of pages10
JournalEuropean Journal of Human Genetics
Issue number10
StatePublished - 22 Oct 2015


Dive into the research topics of 'Redefining the MED13L syndrome'. Together they form a unique fingerprint.

Cite this